Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Molecular Diagnostics Market


6. Market Share Analysis – Global Molecular Diagnostics

6.1 By Products
6.2 By Application
6.3 By Technology
6.4 By End User
6.5 By Region


7. Product - Global Molecular Diagnostics Market

7.1 Reagents
7.2 Intruments
7.3 Others


8. Application - Global Molecular Diagnostics Market

8.1 Infectious Disease
8.2 Blood Screening
8.3 Genetic Testing
8.4 Oncology Testing


9. Technology - Global Molecular Diagnostics Market

9.1 Polymerase Chain Reaction
9.2 In Situ Hybridization
9.3 Isothermal Amplification
9.4 Sequecing
9.5 Mass Spectrometry
9.6 Chips & Microarrays
9.7 Others


10. End User - Global Molecular Diagnostics Market

10.1 Hospital
10.2 Cliniques
10.3 Others


11. Region - Global Molecular Diagnostics Market

11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 South America
11.5 Middle East and Africa


12. Porters Five Forces

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes


13. Company Analysis

13.1 Abbott Laboratories

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Sales Analysis

13.2 Myriad Genetics

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Sales Analysis

13.3 Roche Diagnostic

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Sales Analysis

13.4 BioMerieux SA

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Sales Analysis

13.5 Danaher Corporation

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Sales Analysis

13.6 Qiagen NV

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Sales Analysis

13.7 GenMark Diagnostics

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Sales Analysis

13.8 Bio rad laboratories, Inc

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Sales Analysis

13.9 Hologic (Gen Probe)

13.9.1 Overview
13.9.2 Recent Development
13.9.3 Sales Analysis



List of Figures

Figure-01: Global – Molecular Diagnostic Market (Billion US$), 2017 – 2021
Figure-02: Global – Forecast for Molecular Diagnostic Market (Billion US$), 2022 – 2027
Figure-03: Product – Reagents Market (Million US$), 2017 – 2021
Figure-04: Product – Forecast for Reagents Market (Million US$), 2022 – 2027
Figure-05: Product – Intruments Market (Million US$), 2017 – 2021
Figure-06: Product – Forecast for Intruments Market (Million US$), 2022 – 2027
Figure-07: Product – Others Market (Million US$), 2017 – 2021
Figure-08: Product – Forecast for Others Market (Million US$), 2022 – 2027
Figure-09: Application – Infectious Disease Market (Million US$), 2017 – 2021
Figure-10: Application – Forecast for Infectious Disease Market (Million US$), 2022 – 2027
Figure-11: Application – Blood Screening Market (Million US$), 2017 – 2021
Figure-12: Application – Forecast for Blood Screening Market (Million US$), 2022 – 2027
Figure-13: Application – Genetic Testing Market (Million US$), 2017 – 2021
Figure-14: Application – Forecast for Genetic Testing Market (Million US$), 2022 – 2027
Figure-15: Application – Oncology Testing Market (Million US$), 2017 – 2021
Figure-16: Application – Forecast for Oncology Testing Market (Million US$), 2022 – 2027
Figure-17: Technology – Polymerase Chain Reaction Market (Million US$), 2017 – 2021
Figure-18: Technology – Forecast for Polymerase Chain Reaction Market (Million US$), 2022 – 2027
Figure-19: Technology – In Situ Hybridization Market (Million US$), 2017 – 2021
Figure-20: Technology – Forecast for In Situ Hybridization Market (Million US$), 2022 – 2027
Figure-21: Technology – Isothermal Amplification Market (Million US$), 2017 – 2021
Figure-22: Technology – Forecast for Isothermal Amplification Market (Million US$), 2022 – 2027
Figure-23: Technology – Sequecing Market (Million US$), 2017 – 2021
Figure-24: Technology – Forecast for Sequecing Market (Million US$), 2022 – 2027
Figure-25: Technology – Mass Spectrometry Market (Million US$), 2017 – 2021
Figure-26: Technology – Forecast for Mass Spectrometry Market (Million US$), 2022 – 2027
Figure-27: Technology – Chips & Microarrays Market (Million US$), 2017 – 2021
Figure-28: Technology – Forecast for Chips & Microarrays Market (Million US$), 2022 – 2027
Figure-29: Technology – Others Market (Million US$), 2017 – 2021
Figure-30: Technology – Forecast for Others Market (Million US$), 2022 – 2027
Figure-31: End User – Hospital Market (Million US$), 2017 – 2021
Figure-32: End User – Forecast for Hospital Market (Million US$), 2022 – 2027
Figure-33: End User – Cliniques Market (Million US$), 2017 – 2021
Figure-34: End User – Forecast for Cliniques Market (Million US$), 2022 – 2027
Figure-35: End User – Others Market (Million US$), 2017 – 2021
Figure-36: End User – Forecast for Others Market (Million US$), 2022 – 2027
Figure-37: North America – Molecular Diagnostic Market (Million US$), 2017 – 2021
Figure-38: North America – Forecast for Molecular Diagnostic Market (Million US$), 2022 – 2027
Figure-39: Europe – Molecular Diagnostic Market (Million US$), 2017 – 2021
Figure-40: Europe – Forecast for Molecular Diagnostic Market (Million US$), 2022 – 2027
Figure-41: Asia Pacific – Molecular Diagnostic Market (Million US$), 2017 – 2021
Figure-42: Asia Pacific – Forecast for Molecular Diagnostic Market (Million US$), 2022 – 2027
Figure-43: South America – Molecular Diagnostic Market (Million US$), 2017 – 2021
Figure-44: South America – Forecast for Molecular Diagnostic Market (Million US$), 2022 – 2027
Figure-45: Middle East and Africa – Molecular Diagnostic Market (Million US$), 2017 – 2021
Figure-46: Middle East and Africa – Forecast for Molecular Diagnostic Market (Million US$), 2022 – 2027
Figure-47: Abbott Laboratories – Global Revenue (Million US$), 2017 – 2021
Figure-48: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-49: Myriad Genetics – Global Revenue (Million US$), 2017 – 2021
Figure-50: Myriad Genetics – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-51: Roche Diagnostic – Global Revenue (Million US$), 2017 – 2021
Figure-52: Roche Diagnostic – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-53: BioMerieux SA – Global Revenue (Million US$), 2017 – 2021
Figure-54: BioMerieux SA – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-55: Danaher Corporation – Global Revenue (Million US$), 2017 – 2021
Figure-56: Danaher Corporation – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-57: Qiagen NV – Global Revenue (Million US$), 2017 – 2021
Figure-58: Qiagen NV – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-59: GenMark Diagnostics – Global Revenue (Million US$), 2017 – 2021
Figure-60: GenMark Diagnostics – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-61: Bio rad laboratories, inc – Global Revenue (Million US$), 2017 – 2021
Figure-62: Bio rad laboratories, inc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-63: Hologic (Gen Probe) – Global Revenue (Million US$), 2017 – 2021
Figure-64: Hologic (Gen Probe) – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Molecular Diagnostic Market Share by Product (Percent), 2017 – 2021
Table-02: Global – Forecast for Molecular Diagnostic Market Share by Product (Percent), 2022 – 2027
Table-03: Global – Molecular Diagnostic Market Share by Application (Percent), 2017 – 2021
Table-04: Global – Forecast for Molecular Diagnostic Market Share by Application (Percent), 2022 – 2027
Table-05: Global – Molecular Diagnostic Market Share by Technology (Percent), 2017 – 2021
Table-06: Global – Forecast for Molecular Diagnostic Market Share by Technology (Percent), 2022 – 2027
Table-07: Global – Molecular Diagnostic Market Share by End Use (Percent), 2017 – 2021
Table-08: Global – Forecast for Molecular Diagnostic Market Share by End Use (Percent), 2022 – 2027
Table-09: Global – Molecular Diagnostic Market Share by Region (Percent), 2017 – 2021
Table-10: Global – Forecast for Molecular Diagnostic Market Share by Region (Percent), 2022 – 2027